IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Ongoing Investigation of Claims against MannKind Corp. & Advises Inves...
January 22 2016 - 9:34PM
Business Wire
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it
is investigating claims of potential misrepresentations by MannKind
Corp. (“MannKind” or the “Company”) (Nasdaq: MNKD). The
investigation focuses on whether the Company and its officers
violated securities laws by issuing misleading information to
investors.
If you purchased or otherwise acquired MannKind shares and would
like more information regarding the investigation, we advise you to
contact Michael Goldberg or Brian Schall of Goldberg Law PC, 13650
Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The investigation concerns whether the Company violated Sections
10(b) and 20(a) of the Securities Exchange Act of 1934.
Specifically, the investigation will focus on the Company’s January
5, 2015 announcement that French pharmaceutical giant Sanofi will
no longer market and distribute Afrezza.
If you have any questions concerning your legal rights in this
case, please immediately contact Goldberg Law PC at 800-977-7401,
or visit our website at http://www.Goldberglawpc.com, or email us
at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160122006020/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.comhttps://twitter.com/search?q=golberglawpc&src=typdhttps://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Mar 2024 to Apr 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Apr 2023 to Apr 2024